Patent details

EP2170959 Title: ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

Basic Information

Publication number:
EP2170959
PCT Application Number:
PCT/US/2008/007463
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP087684858
PCT Publication Number:
WO/2008/156712
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
French Title of Invention:
ANTICORPS DIRIGÉS CONTRE LE RÉCEPTEUR HUMAIN DE MORT PROGRAMMÉE PD-1
German Title of Invention:
ANTIKÖRPER GEGEN DEN HUMANEN PROGRAMMED DEATH REZEPTOR PD-1
SPC Number:
92936

Dates

Filing date:
13/06/2008
Grant date:
02/10/2013
EP Publication Date:
02/10/2013
PCT Publication Date:
24/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/04/2010
EP B1 Publication Date:
02/10/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2008
 
 

Name:
Merck Sharp & Dohme B.V.
Address:
Waarderweg 39, 2031 BN Haarlem, Netherlands (NL)

Agent

Name:
MARKS & CLERK LLP
From:
07/11/2013
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
VAN EENENNAAM Hans
Address:
Netherlands (NL)

2

Name:
DULOS Gradus Johannes
Address:
Netherlands (NL)

3

Name:
CARVEN Gregory John
Address:
United States (US)

Priority

Priority Number:
944583 P
Priority Date:
18/06/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/05/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56